Cargando…

Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study

BACKGROUND: Randomized controlled trials have shown a higher sensitivity and longer negative predictive value of high-risk human papillomavirus (HPV) testing than cytology for cervical cancer screening; however, little is known about the effectiveness of HPV testing in middle-income countries. Under...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yanxia, Bao, Heling, Ma, Lan, Song, Bo, Di, Jiangli, Wang, Linhong, Gao, Yanqiu, Ren, Wenhui, Wang, Shi, Wang, Hai-Jun, Wu, Jiuling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281674/ https://www.ncbi.nlm.nih.gov/pubmed/34261463 http://dx.doi.org/10.1186/s12916-021-02026-0

Ejemplares similares

Age‐specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross‐sectional study
por: Bao, Heling, et al.
Publicado: (2022)

A nationally quasi-experimental study to assess the impact of partial organized breast and cervical cancer screening programme on participation and inequalities
por: Bao, Heling, et al.
Publicado: (2020)

Knowledge of Cervical Cancer Screening among Women across Different Socio-Economic Regions of China
por: Di, Jiangli, et al.
Publicado: (2015)

Cervical Cancer Screening Coverage — China, 2018–2019
por: Zhang, Mei, et al.
Publicado: (2022)

Effect of introducing human papillomavirus genotyping into real-world screening on cervical cancer screening in China: a retrospective population-based cohort study
por: Dong, Binhua, et al.
Publicado: (2021)

Women's perspectives on human papillomavirus self‐sampling in the context of the UK cervical screening programme
por: Williams, Denitza, et al.
Publicado: (2017)

How Can a High-Performance Screening Strategy Be Determined for Cervical Cancer Prevention? Evidence From a Hierarchical Clustering Analysis of a Multicentric Clinical Study
por: Bao, Heling, et al.
Publicado: (2022)

Prevalence of High-Risk Human Papillomavirus in Cervical Intraepithelial Neoplasia in the Pre-Vaccine Era — China, 2017–2018
por: Bao, Heling, et al.
Publicado: (2022)

Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme
por: Nygård, Mari, et al.
Publicado: (2014)

Overview of organisational methods of primary cervical lesion screening programmes that use human papillomavirus testing
por: Marchadier, Agathe, et al.
Publicado: (2023)

Comparison of the detection rate of cervical lesion with TruScreen, LBC test and HPV test: A Real-world study based on population screening of cervical cancer in rural areas of China
por: Ma, Yu, et al.
Publicado: (2020)

Cost-Utility of a Two-Dose Human Papillomavirus Vaccination Programme Added to Cervical Cancer Screening Compared with Cervical Cancer Screening Alone in Korea
por: Lee, Hyunju, et al.
Publicado: (2019)

Human papillomavirus testing in cervical cancer screening
por: Franceschi, S, et al.
Publicado: (2005)

An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme
por: Sherlaw-Johnson, C, et al.
Publicado: (2004)

Significant variations in the cervical cancer screening rate in China by individual‐level and geographical measures of socioeconomic status: a multilevel model analysis of a nationally representative survey dataset
por: Bao, Heling, et al.
Publicado: (2018)

Cost-effectiveness of artificial intelligence-assisted liquid-based cytology testing for cervical cancer screening in China
por: Shen, Mingwang, et al.
Publicado: (2023)

Breast Cancer Screening Coverage — China, 2018–2019
por: Zhang, Mei, et al.
Publicado: (2023)

Cervical Human Papillomavirus Screening among Older Women
por: Grainge, Matthew J., et al.
Publicado: (2005)

The artificial intelligence‐assisted cytology diagnostic system in large‐scale cervical cancer screening: A population‐based cohort study of 0.7 million women
por: Bao, Heling, et al.
Publicado: (2020)

Impact of cervical screening by human papillomavirus genotype: Population-based estimations
por: Wang, Jiangrong, et al.
Publicado: (2023)

Correlates of women’s intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval
por: Ogilvie, Gina S., et al.
Publicado: (2016)

Participation in the nationwide cervical cancer screening programme in Denmark during the COVID-19 pandemic: An observational study
por: Olesen, Tina Bech, et al.
Publicado: (2023)

Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis
por: Kulasingam, Shalini L, et al.
Publicado: (2008)

Self-Sampling for Human Papillomavirus Testing among Non-Attenders Increases Attendance to the Norwegian Cervical Cancer Screening Programme
por: Enerly, Espen, et al.
Publicado: (2016)

The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China
por: Wang, Shizhuo, et al.
Publicado: (2012)

Telepathology in cervical and breast cancer screening programmes
por: Colombari, Romano, et al.
Publicado: (2013)

Human papillomavirus (HPV) testing for cervical cancer screening in a middle-income country: comment on a large real-world implementation study in China
por: Thomsen, Louise T., et al.
Publicado: (2021)

Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan
por: Sasaki, Yuri, et al.
Publicado: (2017)

Utility of Human Papillomavirus Testing for Cervical Cancer Screening in Korea
por: Kim, Mee-seon, et al.
Publicado: (2020)

Quality assurance in human papillomavirus testing for primary cervical screening
por: Cuschieri, Kate, et al.
Publicado: (2023)

Breast Cancer Awareness and Association with Frequency of Screening Among Women — China, 2020
por: Bao, Heling, et al.
Publicado: (2023)

Concurrent participation in breast, cervical, and colorectal cancer screening programmes in Denmark: A nationwide registry-based study
por: Njor, Sisse Helle, et al.
Publicado: (2023)

Psychosexual distress following routine primary human papillomavirus testing: a longitudinal evaluation within the English Cervical Screening Programme
por: Bennett, KF, et al.
Publicado: (2020)

Smear misclassification in a cervical cancer screening programme.
por: Lynge, E., et al.
Publicado: (1993)

Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping
por: Ge, Shichao, et al.
Publicado: (2012)

Human Papillomavirus Types Distribution in Organised Cervical Cancer Screening in France
por: Heard, Isabelle, et al.
Publicado: (2013)

Is a delay in the introduction of human papillomavirus-based cervical screening affordable?
por: Castañon, Alejandra, et al.
Publicado: (2018)

Evaluation of human-papillomavirus screening for cervical cancer in China’s rural population
por: Li, Ling, et al.
Publicado: (2019)

Validation of the cobas 6800 human papillomavirus test in primary cervical screening
por: Sundström, Karin, et al.
Publicado: (2021)

Human papillomavirus testing as a primary screening tool for cervical cancer
por: Cho, Hyun-Woong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_icqfmb3oelt5hi1ng5nsgeijna